Viral Pharyngitis Medication
- Author: KoKo Aung, MD, MPH, FACP; Chief Editor: Burke A Cunha, MD more...
Medication Summary
The goal of pharmacotherapy is primarily to reduce morbidity. Analgesics/antipyretics and topical anesthetics are mainstay of pharmacological treatment. Most of these agents have been available for many years and are available without prescription.
A recent prospective, randomized, double-blind, placebo-controlled, multicenter study[12] showed that patients with viral pharyngitis who received chlorhexidine gluconate/benzydamine hydrochloride mouth spray reported less pain on both day 3 and day 7. Further, recipients of chlorhexidine/benzydamine reported a significantly better quality of life on day 7. Chlorhexidine/benzydamine was well tolerated, and no serious adverse events were observed during this trial.
Analgesics/antipyretics
Class Summary
These agents are often helpful in relieving the pain and fever associated with pharyngitis.
Acetaminophen (Tylenol)
Relieves pain by elevation of the pain threshold. Reduces fever by acting directly on hypothalamic heat-regulating centers, which increases dissipation of body heat via vasodilation and sweating.
Ibuprofen (Advil, Motrin)
Inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis.
Topical Anesthetics
Class Summary
These agents soothe irritated or inflamed mucous membranes associated with sore throat.
Benzocaine (Trocaine, Benzocol, Cylex, Cepacol Maximum Strength)
Lozenges or gargle reduces pain associated with pharyngitis. Inhibits neuronal membrane depolarization, blocking nerve impulses.
Antiviral Agents
Class Summary
These agents are used specifically to treat viral infections. They are available for only a few viruses.
Amantadine (Symmetrel)
Active against influenza A virus. Has little or no activity against influenza B virus isolates. Mechanism of antiviral action is unclear. Prevents release of infectious viral nucleic acid into the host cell by interfering with the function of the transmembrane domain of the viral M2 protein. In certain cases, known to prevent virus assembly during virus replication. Treatment begun within 48 h of the onset of symptoms decreases the duration of fever and other symptoms.
Rimantadine (Flumadine)
Inhibits viral replication of influenza A virus H1N1, H2N2, and H3N2 with little or no activity against influenza B virus. Prevents penetration of the virus into the host by inhibiting uncoating of influenza A. Does not appear to interfere with the immunogenicity of inactivated influenza A vaccine. Can be used together during an outbreak.
Oseltamivir (Tamiflu)
Inhibits neuraminidase, which is a glycoprotein on the surface of influenza virus that destroys an infected cell's receptor for viral hemagglutinin. By inhibiting viral neuraminidase, decreases release of viruses from infected cells and thus viral spread. Effective to treat influenza A or B. Start within 40 h of symptom onset. Available as capsules and an oral suspension.
Acyclovir (Zovirax)
Synthetic purine nucleoside analogue with in vitro and in vivo inhibitory activity against HSV-1, HSV-2, and VSV. Inhibitory activity is highly selective because of its affinity for the enzyme thymidine kinase (TK) encoded by HSV and VZV.
Valacyclovir (Valtrex)
Prodrug rapidly converted to the active drug acyclovir. More expensive but has a more convenient dosing regimen than acyclovir.
Famciclovir (Famvir)
Prodrug that when biotransformed into active metabolite, penciclovir, may inhibit viral DNA synthesis/replication.
Antiviral Agent, Inhalation Therapy
Zanamivir (Relenza)
Inhibitor of neuraminidase, which is a glycoprotein on the surface of the influenza virus that destroys the infected cell's receptor for viral hemagglutinin. By inhibiting viral neuraminidase, release of viruses from infected cells and viral spread are decreased. Effective against both influenza A and B. To be inhaled through Diskhaler oral inhalation device. Circular foil discs containing 5-mg blisters of drug are inserted into supplied inhalation device.
Perkins A. An approach to diagnosing the acute sore throat. Am Fam Physician. Jan 1997;55(1):131-8, 141-2. [Medline].
Bisno AL. Acute pharyngitis. N Engl J Med. Jan 18 2001;344(3):205-11. [Medline].
Weckx LL, Ruiz JE, Duperly J, et al. Efficacy of celecoxib in treating symptoms of viral pharyngitis: a double-blind, randomized study of celecoxib versus diclofenac. J Int Med Res. Mar-Apr 2002;30(2):185-94. [Medline].
Graham A, Fahey T. Evidence based case report. Sore throat: diagnostic and therapeutic dilemmas. BMJ. Jul 17 1999;319(7203):173-4. [Medline].
Rimantadine for prevention and treatment of influenza. Med Lett Drugs Ther. Nov 26 1993;35(910):109-10. [Medline].
Two neuraminidase inhibitors for treatment of influenza. Med Lett Drugs Ther. Oct 8 1999;41(1063):91-3. [Medline].
Jefferson T, Jones M, Doshi P, Del Mar C. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ. Dec 8 2009;339:b5106. [Medline]. [Full Text].
Jefferson T, Doshi P, Thompson M, Heneghan C. Ensuring safe and effective drugs: who can do what it takes?. BMJ. Jan 11 2011;342:c7258. [Medline].
Jefferson T, Jones MA, Doshi P, Del Mar CB, Heneghan CJ, Hama R, Thompson MJ. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children - a review of clinical study reports (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 1. Art. No.: CD008965 [database online]. John Wiley & Sons, Ltd; 2011. Updated 4 May 2011.
CDC. Seansonal Flu Weekly Report. Available at http://www.cdc.gov/flu/weekly/index.htm. Accessed July 29, 2011.
WHO. Infleunza Update. Available at http://www.who.int/csr/disease/influenza/latest_update_GIP_surveillance/en/. Accessed July 29, 2011.
Cingi C, Songu M, Ural A, Yildirim M, Erdogmus N, Bal C. Effects of chlorhexidine/benzydamine mouth spray on pain and quality of life in acute viral pharyngitis: a prospective, randomized, double-blind, placebo-controlled, multicenter study. Ear Nose Throat J. Nov 2010;89(11):546-9. [Medline].
Ebell MH, Smith MA, Barry HC, et al. The rational clinical examination. Does this patient have strep throat?. JAMA. Dec 13 2000;284(22):2912-8. [Medline].
Little P, Gould C, Williamson I, Warner G, Gantley M, Kinmonth AL. Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. BMJ. Aug 9 1997;315(7104):350-2. [Medline].
McIsaac WJ, White D, Tannenbaum D, et al. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ. Jan 13 1998;158(1):75-83. [Medline].
Singh S, Dolan JG, Centor RM. Optimal management of adults with pharyngitis--a multi-criteria decision analysis. BMC Med Inform Decis Mak. Mar 13 2006;6:14. [Medline].
Cunha BA. Group A streptococcal pharyngitis. Emerg Med. 1990;22:93-96.
Cunha BA. Group A streptococcal pharyngitis versus colonization. Intern Med. 1994;15:18-19.
Cunha BA. The Sore Throat: Mycoplasma pneumoniae pharyngitis. Emerg Med. 1988;20:245-252.
Gwaltney JM Jr, Bisno AL. Pharyngitis. In: Mandell GI, Bennett JE, Dolin R, eds. Mandell, Douglas & Bennett's Principles of Infectious Diseases. Vol 1. Churchill Livingstone; 2000:656-62.
Huovinen P, Lahtonen R, Ziegler T, et al. Pharyngitis in adults: the presence and coexistence of viruses and bacterial organisms. Ann Intern Med. Apr 15 1989;110(8):612-6. [Medline].
McIsaac WJ, Goel V, Slaughter PM. Reconsidering sore throats. Part 2: Alternative approach and practical office tool. Can Fam Physician. Mar 1997;43:495-500. [Medline].
McIsaac WJ, Goel V, Slaughter PM, et al. Reconsidering sore throats. Part I: Problems with current clinical practice. Can Fam Physician. Mar 1997;43:485-93. [Medline].
Paradise JL. Etiology and management of pharyngitis and pharyngotonsillitis in children: a current review. Ann Otol Rhinol Laryngol Suppl. Jan 1992;155:51-7. [Medline].
Pichichero ME. Sore throat after sore throat after sore throat. Are you asking the critical questions?. Postgrad Med. Jan 1997;101(1):205-6, 209-12, 215-8, passim. [Medline].
Wolter JM. Management of a sore throat. Antibiotics are no longer appropriate. Aust Fam Physician. Apr 1998;27(4):279-81. [Medline].
Yoda K, Sata T, Kurata T, et al. Oropharyngotonsillitis associated with nonprimary Epstein-Barr virus infection. Arch Otolaryngol Head Neck Surg. Feb 2000;126(2):185-93. [Medline].
Print
